other
-
-
Apr 16, 2021 other
-
-
other
-
Notice Regarding Disclosure of “Names of Drug Product Manufacturers” for Products that KYOSOMIRAI PHARMA Holds Marketing Approvals(107 KB)
-
-
Apr 05, 2021 other
-
-
other
-
Notice Regarding Free Provision of Nafamostat Mesilate Products(106 KB)
-
-
Mar 11, 2021 other
-
-
other
-
Notice of the Posting of a Gain on Sale of Investment Securities (Extraordinary Income)(64 KB)
-
-
Dec 16, 2020 other
-
-
other
-
Regarding a Reduction of Directors’ Compensation and Compliance Enhancement Initiatives for Recurrence Prevention(148 KB)
-
-
Dec 09, 2020 other
-
-
other
-
Regarding accusation of a suspected violation of the Antimonopoly Act(113 KB)
-
-
Oct 13, 2020 other
-
-
other
-
Notice regarding the search of a consolidated subsidiary by the Tokyo District Public Prosecutors Office and the Japan Fair Trade Commission(76 KB)
-
-
Sep 16, 2020 other
-
-
other
-
Announcement of the launch of a large and highly-functional logistics center, “TBC Dynabase” – Achieving tremendous improvement in the efficiency of pharmaceutical distribution and disaster response in the Tokyo metropolitan area –(455 KB)
-
-
Jul 03, 2020 other
-
-
other
-
Notice Regarding Efforts to Strengthen Compliance(130 KB)
-
-
Nov 27, 2019 other
-
-
other
-
Notice regarding Onsite Inspection at a Consolidated Subsidiary by the Japan Fair Trade Commission(37 KB)
-
-
Apr 01, 2019 other
-
-
other
-
Notice of the Establishment of a Joint Company for Generic Drugs between TOHO HOLDINGS CO., LTD. and SUZUKEN CO., LTD.(93 KB)
-
-
Nov 21, 2018 other
-
-
other
-
NoticeRegarding Start of Operations at the New High-Functioning Distribution Center, “TBC Hiroshima”(122 KB)
-
-
Nov 02, 2018 other
-
-
other
-
Notice Regarding Contract on Distribution Operation of Haemophilia B Drug by Novo Nordisk Pharma Ltd.(72 KB)
-
-
Jul 27, 2018 other
-
-
other
-
Notice regarding the Transfer of Marketing Approvals and Sales Rights for Pharmaceuticals from FUJIFILM Pharma to KYOSOMIRAI PHARMA(66 KB)
-
-
Jul 24, 2018 other
-
-
other
-
Notice of Signing the Letter of Intent regarding Shared Use of Customer Support Systems, etc.(84 KB)
